Research Article

Non-Alcoholic Fatty Liver and Fatty Pancreas Diseases Associate with Acute Pancreatitis

Volume: 44 Number: 4 December 31, 2022
EN

Non-Alcoholic Fatty Liver and Fatty Pancreas Diseases Associate with Acute Pancreatitis

Abstract

Objective: Fat accumulation in the liver and pancreas are clinical manifestations of metabolic syndrome associated with inflammation. It aimed to investigate the effects of the computed tomography (CT) estimated non-alcoholic fatty liver disease (NAFLD) and non-alcoholic fatty pancreas disease (NAFPD) on the development of acute pancreatitis in this study. Patients and methods: This retrospective and cross-sectional study consisted of 194 participants admitted to the hospital with an abdominal pain complaint and underwent an abdominal CT scan during the investigation of the differential diagnosis. Medical database records of patients were investigated. Groups were consisted of according to the presence of acute pancreatitis as study and control. Attenuation measurements of the liver and pancreas were determined according to abdominal CT. Results: A statistical significance was observed for the development of acute pancreatitis when patients with normoglycemia were compared to patients with prediabetes and diabetes. Percentages of NAFLD and NAFPD according to the median of CT attenuation difference between pancreas and spleen values were elevated in the study group. A logistic regression model revealed that prediabetes, type 2 diabetes, NAFLD, and NAFPD, according to median value, were risk factors for acute pancreatitis (p<0.001, =0.001, =0.02, and =0.022). Discussion: NAFLD and NAFPD, according to the median value of patients without pancreatitis, were determined as independent risk factors for the development of acute pancreatitis.

Keywords

References

  1. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome a new worldwide definition. Lancet 2005; 366: 1059-62
  2. Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014; 2014: 943162, DOI:10.1155/2014/943162.
  3. Yki-Jarvinen H. Non-alcoholic fatty liver diseaseas a cause and consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2014; 2: 901-10.
  4. Contos MJ, Choudhury J, Mills AS, Sanyal AJ. The histologic spectrum of nonalcoholic fatty liver disease. Clin Liver Dis 2004; 8(3): 481–500 10.1016/j.cld.2004.04.013.
  5. Lee JS, Kim SH, Jun DW, et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol 2009; 15: 1869-75.
  6. Rosenblatt R, Mehta A, Snell D, et al. Ultrasonographic nonalcoholic fatty pancreas is associated with advanced fibrosis in NAFLD: A retrospective analysis. Dig Dis Sci 2018; doi:10.1007/s10620-018-5295-x
  7. Lankish PG, Apte M, Banks PA. Acute pancreatitis. Lancet 2015; 4; 386(9988) :85-96. doi:10.1016/S0140-6736(14)60649-8.
  8. Mikolasevic I, Milic S, Orlic L, et al. Metabolic syndrome and acute pancreatitis. Eur J Intern Med 2016; 32:79-83. doi: 10.1016/j.ejim.2016.04.004.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

December 31, 2022

Submission Date

February 28, 2022

Acceptance Date

December 30, 2022

Published in Issue

Year 2022 Volume: 44 Number: 4

AMA
1.Ahbab S, Keskin A, Hoca E, et al. Non-Alcoholic Fatty Liver and Fatty Pancreas Diseases Associate with Acute Pancreatitis. CMJ. 2022;44(4):436-442. doi:10.7197/cmj.1079443

Cited By